Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: Efficacy, tolerability, viral kinetics and cytokine response

Y. Rotman, B. B. Borg, A. Soza, J. J. Feld, A. A. Modi, R. Loomba, G. Lutchman, E. Rivera, E. Doo, M. G. Ghany, T. Heller, A. U. Neumann, T. J. Liang, J. H. Hoofnagle

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Low- and standard-dose peginterferon alfa-2a for chronic hepatitis C, genotype 2 or 3: Efficacy, tolerability, viral kinetics and cytokine response'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases